PTH(1-34) suppresses appositional bone formation by cultured rat cranial osteoblasts

Area of Science:

• Bone Biology
• Endocrinology
• Cell Biology

Background:

• Parathyroid hormone (PTH) is known to stimulate osteoblast proliferation in vitro and exhibit anabolic effects in vivo with intermittent administration.
• Intermittent PTH administration is a therapeutic strategy explored for promoting bone formation.

Purpose of the Study:

• To investigate the effect of short-term intermittent parathyroid hormone (PTH(1-34)) exposure on bone formation in vitro using rat primary calvarial osteoblasts.
• To determine if intermittent PTH(1-34) administration promotes osteogenesis in an experimental system designed for appositional bone formation.

Main Methods:

• Primary rat calvarial osteoblasts were cultured and exposed to varying concentrations of rat PTH(1-34) (10(-12) to 10(-7) mol/L).
• Different intermittent administration schedules were employed, including 24-hour exposure on specific days, 24-hour exposure on multiple days, and 6-hour pulses every 48 hours.
• Bone formation was assessed to evaluate the osteogenic response.

Main Results:

• Unexpectedly, PTH(1-34) exposure suppressed bone formation across all tested concentrations, even at the lowest dose.
• Even brief intermittent pulses of PTH(1-34) every other day led to suppressed osteogenic capacity.
• High concentrations of PTH(1-34) for a single day per week completely prevented appositional bone formation.

Conclusions:

• Intermittent PTH(1-34) administration demonstrated an inhibitory effect on bone formation in this in vitro model.
• The findings suggest that PTH pulses may not necessarily increase bone formation in already differentiated osteoblasts.
• This challenges the conventional understanding of PTH's anabolic role in differentiated osteoblasts.